Omega-3 fatty acids in inflammation and autoimmune diseases

Journal of the American College of Nutrition

Volumn 21, Issue 6, 2002, Pages 495-505

  Simopoulos, Artemis P ^a  

^a Center for Nutrition Genetics & Health   (United States)

Author keywords

Background diet; Cardiovascular disease and major depression autoimmune diseases; Il 1; Il 6; Inflammation; Omega 6 omega 3 ratio; Tnf

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; INTERLEUKIN 1; INTERLEUKIN 6; LEUKOTRIENE B4; LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

AGING; ANTIINFLAMMATORY ACTIVITY; ASTHMA; AUTOIMMUNE DISEASE; CANCER; CLINICAL TRIAL; CROHN DISEASE; DIET SUPPLEMENTATION; GENE EXPRESSION; HUMAN; IMMUNOMODULATION; INFLAMMATION; ISCHEMIC HEART DISEASE; LUPUS ERYTHEMATOSUS; MAJOR DEPRESSION; MIGRAINE; MULTIPLE SCLEROSIS; NONHUMAN; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ULCERATIVE COLITIS;

ALPHA-LINOLENIC ACID; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; ASTHMA; AUTOIMMUNE DISEASES; CARDIOVASCULAR DISEASES; CYTOKINES; DEPRESSIVE DISORDER, MAJOR; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FATTY ACIDS, UNSATURATED; FISH OILS; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; PROSTAGLANDINS; PSORIASIS;

ANIMALIA;

EID: 0036931477     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2002.10719248     Document Type: Article

References (100)

1. Kromann N, Green A: Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand 208:401-406, 1980.
2. Dyerberg J, Bang HO: Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 2:433-435, 1979.
3. Hirai A, Hamazaki T, Terano T, Nishikawa T, Tamura Y, Kumagai A, Sajiki J: Eicosapentaenoic acid and platelet function in Japanese. Lancet 2:1132 [Letter], 1982.
4. Black KL, Culp B, Madison D, Randall OS, Lands WE: The protective effects of dietary fish oil on focal cerebral infarction. Prostaglandins Med 3:257-268, 1979.
5. Culp BR, Lands WE, Lucches BR, Pitt B, Romson J: The effect of dietary supplementation of fish oil on experimental myocardial infarction. Prostaglandins. 20:1021-1031, 1980.
6. Prickett JD, Robinson DR, Steinberg AD: Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB NZW F1 mice. J Clin Invest 68:556-559, 1981.
7. Prickett JD, Robinson DR, Steinberg AD: Effects of dietary enrichment with eicosapentaenoic acid upon autoimmune nephritis in female NZB NZW F1 mice. Arthritis Rheum 26:133-139, 1983.
8. Karmali RA, Marsh J, Fuchs C: Effect of omega-3 fatty acids on growth of a rat mammary tumor. J Natl Cancer Inst 73:457-461, 1984.
9. Simopoulos AP: Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 54:438-463, 1991.
10. Weber PC, Fischer S, von Schacky C, Lorenz R, Strasser T: Dietary omega-3 polyunsaturated fatty acids and eicosanoid formation in man. In Simopoulos AP, Kifer RR, Martin RE (eds): "Health Effects of Polyunsaturated Fatty Acids in Seafoods." Orlando: Academic Press, pp 49-60, 1986.
11. Lewis RA, Lee TH, Austen KF: Effects of omega-3 fatty acids on the generation of products of the 5-lipoxygenase pathway. In Simopoulos AP, Kifer RR, Martin RE (eds): "Health Effects of Polyunsaturated Fatty Acids in Seafoods." Orlando, Academic Press, pp 227-238, 1986.
12. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM: Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2:757-761, 1989.
13. Leaf A: Cardiovascular effects of fish oils. Beyond the platelet. Circulation 82:624-628, 1990.
14. Leaf A, Weber PC: Cardiovascular effects of n-3 fatty acids. N Engl J Med 318:549-557, 1988.
15. Simopoulos AP, Kifer RR, Martin RE (eds): "Health Effects of Polyunsaturated Fatty Acids in Seafoods." Academic Press, Orlando, 1986.
16. Simopoulos AP, Kifer RR, Martin RE, Barlow SM (eds): "Health Effects of w3 Polyunsaturated Fatty Acids in Seafoods," vol. 66, World Rev Nutr Diet. Basel: Karger, 1991.
17. Von Schacky C: Prophylaxis of atherosclerosis with marine omega-3 fatty acids: a comprehensive strategy. Ann Intern Med 107:890-899, 1988.
18. Seed MP, Willoughby DA: COX-2, HO NO! Cyclooxygenase-2, heme oxygenase and nitric oxide synthase: their role and interactions in inflammation. BIRAs Symposium, Saint Bartholomew's Hospital, London, 26 April 1996. Inflamm Res 46: 279-281, 1997.
19. Laird JM, Herrero JF, Garcia de la Rubia P, Cervero F: Analgesic activity of the novel COX-2 preferring NSAID, meloxicam in mono-arthritic rats: central and peripheral components. Inflamm Res 46:203-210, 1997.
20. Sheng GG, Shao J, Sheng H, Hooton EB, Isakson PC, Morrow JD, Coffey Jr RJ, DuBois RN, Beauchamp RD: A selective cyclooxygenase 2 inhibitor suppresses the growth of H-rastransformed rat intestinal epithelial cells. Gastroenterology 113: 1883-1891, 1997.
21. Singer P, Hueve J: Blood pressure-lowering effect of fish oil, propranolol and the combination of both in mildly hypertensive patients. World Rev Nutr Diet 66:522 [Abstract], 1991.
22. Kremer JM, Lawrence DA, Jubiz W: Different doses of fish-oil fatty acid ingestion in active rheumatoid arthritis: a prospective study of clinical and immunological parameters. In Galli C, Simopoulos AP (eds): "Dietary 3 and 6 Fatty Acids: Biological Effects and Nutritional Essentiality." New York: Plenum, pp 343-350, 1989.
23. Kremer JM, Robinson DR: Studies of dietary supplementation with _3 fatty acids in patients with rheumatoid arthritis. World Rev Nutr Diet 66:367-382, 1991.
24. Allen BR: Fish oil in combination with other therapies in the treatment of psoriasis. In Simopoulos AP, Kifer RR, Martin RE, Barlow SM (eds): "Health Effects of 3 Polyunsaturated Fatty Acids in Seafoods," vol. 66, World Rev Nutr Diet. Basel: Karger, pp 436-445, 1991.
25. Stenson WF, Cort D, Rodgers J, Burakoff R, DeSchryver-Kecskemeti K, Gramlich L, Beeken W: Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 116:609-614, 1992.
26. Dehmer GJ, Popma JJ, van den Berg EK, Eichhorn EJ, Prewitt JB, Campbell WB, Jennings L, Willerson JT, Schmitz JM: Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med 319:733-40, 1988.
27. Fernandes G: Dietary lipids and risk of autoimmune disease. Clin Immunol Immunopathol 72:193-197, 1994.
28. Clarke SD: Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome. J Nutr 131:1129-1132, 2001.
29. Price PT, Nelson CM, Clarke SD: Omega-3 polyunsaturated fatty acid regulation of gene expression. Curr Opin Lipidol 11:3-7, 2000.
30. Jump DB, Clarke SD: Regulation of gene expression by dietary fat. Annu Rev Nutr 19:63-90, 1999.
31. Kehn P, Fernandes G: The importance of omega-3 fatty acids in the attenuation of immuno-mediated diseases. J Clin Immunol 21:99-101, 2001.
32. Chandrasekar B, Fernandes G. Decreased pro-inflammatory cytokines and increased antioxidant enzyme gene expression by-3 lipids in murine lupus nephritis. Biochem Biophys Res Commun 200:893-898, 1994.
33. Cleland LG, James MJ: Rheumatoid arthritis and the balance of dietary N-6 and N-3 essential fatty acids. Br J Rheumatol 36: 513-514, 1997.
34. Cleland LG, Hill CL, James MJ: Diet and arthritis. Baillieres Clin Rheumatol 9:771-785, 1995.
35. Broughton KS, Johnson CS, Pace BK, Liebman M, Kleppinger KM: Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr 65: 1011-1017, 1997.
36. Gibney MJ, Hunter B: The effects of short-and long-term supplementation with fish oil on the incorporation of n-3 polyunsaturated fatty acids into cells of the immune system in healthy volunteers. Eur J Clin Nutr 47:255-259, 1993.
37. Marangoni F, Angeli MT, Colli S, Eligini S, Tremoli E, Sirtori CR, Galli C: Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout. Biochim Biophys Acta 1210:55-62, 1993.
38. Weber PC, Leaf A: Cardiovascular effects of omega 3 fatty acids. Atherosclerosis risk factor modification by omega 3 fatty acids. In Simopoulos AP, Kifer RR, Martin RE, Barlow SM (eds): "Health Effects of w3 Polyunsaturated Fatty Acids in Seafoods," vol. 66, World Rev Nutr Diet. Basel: Karger, pp 218-232, 1991.
39. Woods A, Brull DJ, Humphries SE, Montgomery HE: Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J 21:1574-83, 2000.
40. Robinson DR, Urakaze M, Huang R, Taki H, Sugiyama E, Knoell CT, Xu L, Yeh ET, Auron PE: Dietary marine lipids suppress continuous expression of interleukin-1 beta gene transcription. Lipids 31 (Suppl): S23-S31, 1996.
41. Simopoulos AP: The role of fatty acids in gene expression: health implications. Ann Nutr Metab 40:303-11, 1996.
42. Dinarello CA: The role of interleukin-1 in disease. N Engl J Med 328:106-113, 1993.
43. Vassalli P: The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10:411-452, 1992.
44. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC, et al.: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320:265-271, 1989.
45. Homan van der Heide JJ, Bilo HJG, Donker JM, Wilmik JM, Tegzess AM: Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants. N Engl J Med 329:729-773, 1993.
46. Donadio Jr JV, Bergstralh EJ, Offord KP, Spencer DC, Holley KE: A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N Engl J Med 331:1194-1199, 1994.
47. Walton AJ, Snaith ML, Locniskar M, Cumberland AG, Morrow WJ, Isenberg DA: Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus. Ann Rheum Dis 50:463-466, 1991.
48. Clark WF, Parbtani A, Naylor CD, Levinton CM, Muirhead N, Spanner E, Huff MW, Philbrick DJ, Holub BJ: Fish oil in lupus nephritis: clinical findings and methodological implications. Kidney Int 44:75-86, 1993.
49. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ: The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63:116-122, 1996.
50. Lokesh BR, Sayers TJ, Kinsella JE: Interleukin-1 and tumor necrosis factor synthesis by mouse peritoneal macrophages is enhanced by dietary n-3 polyunsaturated fatty acids. Immunol Lett 23:281-285, 1990.
51. Hardardottir I, Kinsella JE: Tumor necrosis factor production by murine resident peritoneal macrophages is enhanced by dietary n-3 polyunsaturated fatty acids. Biochim Biophys Acta 1095: 187-195, 1991.
52. Blok WL, Vogels MT, Curfs JH, Eling WM, Buurman WA, van der Meer JW: Dietary fish-oil supplementation in experimental gram-negative infection and in cerebral malaria in mice. J Infect Dis 165:898-903, 1992.
53. Ertel W, Morrison MH, Ayala A, Chaudry IH: Modulation of macrophage membrane phospholipids by n-3 polyunsaturated fatty acids increases interleukin 1 release and prevents suppression of cellular immunity following hemorrhagic shock. Arch Surg 128:15-20, 1993.
54. Blok WL, de Bruijn MF, Leenen PJ, Eling WM, van Rooijen N, Stanley ER, Buurman WA, van der Meer JW: Dietary n-3 fatty acids increase spleen size and postendotoxin circulating TNF in mice; role of macrophages, macrophage precursors, and colonystimulating factor-1. J Immunol 157:5569-5573, 1996.
55. Blok WL, Katan MB, van der Meer JW: Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr 126:1515-1533, 1996.
56. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809, 1993.
57. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-26, 1999.
58. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q: Is atherosclerosis an immunologically mediated disease? Immunol Today 16:27-33, 1995.
59. Fogari R, Zoppi A, Marasi G, Vanasia A, Villa G: Associations between plasma fibrinogen levels and cardiovascular risk factors in hypertensive men. J Cardiovasc Risk 1:341-345, 1994.
60. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC: C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312:1061-1065, 1996.
61. Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP, Camm AJ, Northfield TC: Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 78:273-277, 1997.
62. Rosengren A, Wilhelmsen L, Welin L, Tsipogianni A, Teger-Nilsson AC, Wedel H: Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. BMJ 300:634-638, 1990.
63. de Maat MP, Pietersma A, Kofflard M, Sluiter W, Kluft C: Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers. Atherosclerosis 121:185-191, 1996.
64. Lee AJ, Smith WC, Lowe GD, Tunstall-Pedoe H: Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. J Clin Epidemiol 43:913-919, 1990.
65. Montgomery HE, Clarkson P, Nwose OM, Mikailidis DP, Jagroop IA, Dollery C, Moult J, Benhizia F, Deanfield J, Jubb M, World M, McEwan JR, Winder A, Humphries S: The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the beta-fibrinogen gene. Arterioscler Thromb Vasc Biol 16:386-391, 1996.
66. Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE: Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators. N Engl J Med 329:1677-1683, 1993.
67. Willich SN, Lewis M, Lowel H, Arntz HR, Schubert F, Schroder R: Physical exertion as a trigger of acute myocardial infarction. Triggers and Mechanisms of Myocardial Infarction Study Group. N Engl J Med 329:1684-1690, 1993.
68. Housley E, Leng GC, Donnan PT, Fowkes FG: Physical activity and risk of peripheral arterial disease in the general population: Edinburgh Artery Study. J Epidemiol Community Health 47:475-480, 1993.
69. Stratton JR, Chandler WL, Schwartz RS, Cerqueira MD, Levy WC, Kahn SE, Larson VG, Cain KC, Beard JC, Abrass IB: Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 83:1692-1697, 1991.
70. Rankinen T, Rauramaa R, Vaisanen S, Penttila I, Saarikoski S, Tuomilehto J, Nissinen A: Inverse relationship between physical activity and plasma fibrinogen in postmenopausal women. Atherosclerosis 102:181-186, 1993.
71. Lassila R, Peltonen S, Lepantalo M, Saarinen O, Kauhanen P, Manninen V: Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin. Arterioscler Thromb 13:1738-1742, 1993.
72. Mori T, Sasaki J, Kawaguchi H, Handa K, Takada Y, Matsunaga A, Kono S, Arakawa K: Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J 129:234-238, 1995.
73. Heinrich J, Schulte H, Schonfeld R, Kohler E, Assmann G: Association of variables of coagulation, fibrinolysis and acutephase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost 73:374-379, 1995.
74. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82:4196-4200, 1997.
75. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW: C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972-978, 1999.
76. Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC: Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 242:237-239, 1989.
77. Khalfoun B, Thibault F, Watier H, Bardos P, Lebranchu Y: Docosahexaenoic and eisosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. In Honn KV, Nigam S, Marnett LJ (eds): "Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury 2." New York: Plenum, 1997.
78. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369-1376, 1998.
79. Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H: Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord 38:35-46, 1996.
80. Maes M, Smith R, Christophe A, Vandoolaeghe E, Van Gastel A, Neels H, Demedts P, Wauters A, Meltzer HY: Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr Scand 95: 212-221, 1997.
81. Peet M, Murphy B, Shay J, Horrobin D: Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43:315-319, 1998.
82. Maes M, Song C, Lin A et al: The effects of psychological stress on the immune system in humans. Biol Psychiatry 42(Suppl):5S, 1997.
83. Maes M, Christophe A, Bosmans E, Lin A, Neels H: In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to psychologic stress. Biol Psychiatry 47:910-920, 2000.
84. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB: Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56:407-412, 1999.
85. Locke CA, Stoll AL: Omega-3 fatty acids in major depression. World Rev Nutr Diet 89:173-85, 2001.
86. Robinson DR, Pricket JD, Makoul GT, Steinberg AD, Colvin RB: Dietary fish oil reduces progression of established renal disease in (NZB NZW) F1 mice and delays renal disease in BXSB and MRL/1 strains. Arthritis Rheum 29:539-546, 1986.
87. Prickett JD, Trentham DE, Robinson DR: Dietary fish oil augments the induction of arthritis in rats immunized with type II collagen. J Immunol 132:725-729, 1984.
88. Robinson DR, Tateno S, Knoell C, Olesiak W, Xu L, Hirai A, Guo M, Colvin RB: Dietary marine lipids suppress murine autoimmune disease. J Int Med 225(Suppl): 211-216, 1989.
89. Kremer JM, Bigauoette J, Michalek AV, Timchalk MA, Lininger L, Rynes RI, Huyck C, Zieminski J, Bartholomew LE: Effects of manipulating dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet i:184-187, 1985.
90. Kremer JM, Jubiz W, Michalek A, Rynes RI, Bartholomew LE, Bigaouette J, Timchalk M, Beeler D, Lininger L: Fish-oil fatty acid supplementation in active rheumatoid arthritis. A doubleblinded, controlled, crossover study. Ann Intern Med 106:497-503, 1987.
91. Sperling RI, Weinblatt M, Robin JL, Ravalese J 3rd, Hoover RL, House F, Coblyn JS, Fraser PA, Spur BW, Robinson DR, et al: Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. Arthritis Rheum 30:988-997, 1987.
92. James MJ, Cleland LG: Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin Arthritis Rheum 27:85-97, 1997.
93. Fortin PR, Lew RA, Liang MH, Wright EA, Beckett LA, Chalmers TC, Sperling RI: Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. J Clin Epidemiol 48:1379-1390, 1995.
94. Elson CO: Genes, microbes, and T cells-new therapeutic targets in Crohn's disease. N Engl J Med 346:614-616, 2002.
95. McCall TB, O'Leary D, Bloomfield J, O'Morain CA: Therapeutic potential of fish oil in the treatment of ulcerative colitis. Aliment Pharmacol Ther 3:415-424, 1989.
96. Salomon P, Kornbluth AA, Janowitz HD: Treatment of ulcerative colitis with fish oil in 3 omega fatty acid: an open trial. J Clin Gastroenterol 12:157-161, 1990.
97. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M: Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 334:1557-1560, 1996.
98. Endres S, Lorenz R, Loeschke: Lipid treatment of inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 2:117-120, 1999.
99. Laitinen LA, Laitinen A, Haahtela T: Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 147:697-704, 1993.
100. Ziboh VA: ω3 polyunsaturated fatty acid constituents of fish oil and the management of skin inflammatory and scaly disorders. In Simopoulos AP, Kifer RR, Martin RE, Barlow SM (eds): "Health Effects of ω3 Polyunsaturated Fatty Acids in Seafoods," vol. 66, World Rev Nutr Diet. Basel: Karger, pp 425-435, 1991.